Related Experiment Video
Updated: May 9, 2025

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
Allergic Fungal Rhinosinusitis Diagnosis, Management, Associated Conditions, Pathophysiology, and Future Directions:
Lauren T Roland1, Cecelia Damask2, Amber U Luong3
1Department of Otolaryngology, Washington University in St Louis, St Louis, Missouri, USA.
Abstract:
Allergic fungal rhinosinusitis (AFRS) is a unique endotype of chronic rhinosinusitis with nasal polyps (CRSwNP). Despite high recurrence rates and often more severe presenting signs compared with other subtypes of CRSwNP, research dedicated to AFRS has been lacking. Diagnostic criteria are outdated, the mechanistic relationship of AFRS to other associated diseases is unclear, and the pathophysiology of disease and risk factors for recurrence have not been well studied. In December 2023, a multidisciplinary group of rhinologists, otolaryngologists, pulmonologists, allergists, immunologists, scientists, and infectious disease experts met at the National Institute of Health to discuss unmet needs for future AFRS research and care, including patient management, diagnostic criteria, severity, pathophysiology, and related conditions. A summary of these clinical and associated research discussions is included below.
Insights
Allergic fungal rhinosinusitis (AFRS) is a severe CRSwNP subtype lacking research. Experts convened to identify key research gaps in AFRS diagnosis, pathophysiology, and management.
Area of Science:
- Otolaryngology
- Allergy and Immunology
- Pulmonology
Background:
- Allergic fungal rhinosinusitis (AFRS) is a distinct endotype of chronic rhinosinusitis with nasal polyps (CRSwNP).
- AFRS exhibits high recurrence rates and severe symptoms compared to other CRSwNP subtypes.
- Significant research gaps exist regarding AFRS, including outdated diagnostic criteria and unclear pathophysiology.
Purpose of the Study:
- To address the unmet needs in Allergic Fungal Rhinosinusitis (AFRS) research and patient care.
- To convene a multidisciplinary expert panel to discuss critical aspects of AFRS.
- To identify future research directions for AFRS diagnosis, management, and understanding.
Main Methods:
- A multidisciplinary meeting was held in December 2023 at the National Institute of Health.
- Experts included rhinologists, otolaryngologists, pulmonologists, allergists, immunologists, scientists, and infectious disease specialists.
- Discussions focused on patient management, diagnostic criteria, disease severity, pathophysiology, and related conditions.
Main Results:
- Identified outdated diagnostic criteria for AFRS.
- Highlighted the unclear mechanistic relationship of AFRS to other diseases.
- Emphasized the need for further study into AFRS pathophysiology and recurrence risk factors.
Conclusions:
- There is a critical need for dedicated research into Allergic Fungal Rhinosinusitis (AFRS).
- Future research should focus on refining diagnostic criteria and understanding disease mechanisms.
- Improved patient management strategies are required for this severe CRSwNP subtype.
More Related Videos
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma-I: Introduction
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...

